IXICO logo

IXI - IXICO Share Price

70p -3.0  -4.1%

Last Trade - 4:27pm

Sector
Healthcare
Size
Micro Cap
Market Cap £34.4m
Enterprise Value £27.1m
Revenue £7.56m
Position in Universe 1241st / 1834
Bullish
Bearish
Unlock IXI Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

IXI Revenue Unlock IXI Revenue

Net Income

IXI Net Income Unlock IXI Revenue

Normalised EPS

IXI Normalised EPS Unlock IXI Revenue

PE Ratio Range

IXI PE Ratio Range Unlock IXI Revenue

Dividend Yield Range

IXI Dividend Yield Range Unlock IXI Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
IXI EPS Forecasts Unlock IXI Revenue
Profile Summary

IXICO plc is a brain health company. The Company's brain health focus includes Alzheimer's disease, Huntington's disease, Parkinson's disease, behavioral health and adolescent mental health. It is a provider of clinical trials services to pharmaceutical companies. Its products include Assessa, mehealth, MyBrainBook and TrialTracker. Assessa is a decision-support tool for healthcare professionals looking to diagnose dementia and detect the underlying causes. mehealth is an online software for clinicians at the point-of-care to support decision making and improve the monitoring and treatment of patients. MyBrainBook is a digital platform to improve the quality of life and service delivery for people living with dementia and their supporters. TrialTracker is a Web-based system that allows users to track their imaging-based research study or clinical trial in real time. It is also collaborating with partners to develop companion digital health products.

Directors
Last Annual September 30th, 2019
Last Interim September 30th, 2019
Incorporated November 28, 1995
Public Since September 4, 2013
No. of Shareholders: n/a
No. of Employees: 68
Sector Healthcare
Industry Biotechnology & Medical Research
Index FTSE Aim All Share ,
Exchange London Stock Exchange (AIM)
Shares in Issue 47,091,292
Free Float (0.0%)
Eligible for
ISAs
SIPPs
IXI Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for IXI
Upcoming Events for IXI
Monday 20th April, 2020 Estimate
Half Year 2020 IXICO PLC Trading Statement Release
Monday 18th May, 2020 Estimate
Half Year 2020 IXICO PLC Earnings Release
Similar to IXI
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.